
Join to View Full Profile
5522 Sepulveda BlvdSherman Oaks, CA 91411
Phone+1 818-990-5020
Fax+1 818-990-8549
Dr. David is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Richard David, MD, is a urologist based in Sherman Oaks, CA, specializing in areas such as sexual health, pelvic reconstructive surgery, urologic oncology, and minimally invasive urologic surgery. He has served as Chief Medical Officer for the Los Angeles Division of Genesis Healthcare Partners a Division of Unio Specialty Care and previously Skyline Urology. He completed his medical education with a residency in surgery and urology at UCLA David Geffen School of Medicine. He continues as a Clinical Professor of Urology Voluntary at UCLA's David Geffen School of Medicine. Dr. David has contributed to the field with publications on bladder cancer detection and prostate health, with several of his works being highly cited. He has also been involved in clinical trials, including one on Vicinium treatment for bladder cancer. His professional recognition includes being named a Super Doctor and earning the title of Fellow from the American College of Surgeons. He has a Masters in Medical Management from USC's Marshall School of Business.
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Urology, 1987 - 1991
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Surgery, 1985 - 1987
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1985
Certifications & Licensure
- CA State Medical License 1986 - 2026
- MT State Medical License 2024 - 2026
- American Board of Urology Urology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Vicinium Treatment for Subjects With Non-muscle Invasive Bladder Cancer Previously Treated With BCG Start of enrollment: 2015 Aug 01
Publications & Presentations
PubMed
- 33 citationsValidation of an mRNA-based Urine Test for the Detection of Bladder Cancer in Patients with Haematuria.Franciscus Johannes P. van Valenberg, Andrew M. Hiar, Ellen Wallace, Julia A. Bridge, Donna Mayne
European Urology Oncology. 2021-02-01 - 67 citationsProstatic Urethral Lift (PUL) for obstructive median lobes: 12 month results of the MedLift Study.Daniel B. Rukstalis, Douglas Grier, Sean P. Stroup, Ronald F. Tutrone, Euclid deSouza
Prostate Cancer and Prostatic Diseases. 2019-09-01 - 65 citationsProspective Validation of an mRNA-based Urine Test for Surveillance of Patients with Bladder CancerF Johannes P van Valenberg, Andrew M. Hiar, Ellen Wallace, Julia A. Bridge, Donna Mayne
European Urology. 2019-05-01
Press Mentions
- Top Prostate Cancer Outpatient Option HIFU Now Covered by MedicareJanuary 10th, 2023
- System to Treat Enlarged Prostate Appears on “The Doctors” National Television ShowNovember 1st, 2016
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: